Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$2.69 - $5.12 $167,468 - $318,750
-62,256 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$2.25 - $7.12 $140,076 - $443,262
62,256 New
62,256 $191,000
Q3 2020

Nov 16, 2020

SELL
$3.46 - $8.39 $272,641 - $661,115
-78,798 Closed
0 $0
Q2 2020

Aug 17, 2020

SELL
$2.37 - $7.14 $199,279 - $600,359
-84,084 Reduced 51.62%
78,798 $466,000
Q1 2020

May 15, 2020

BUY
$2.46 - $5.84 $38,189 - $90,660
15,524 Added 10.53%
162,882 $432,000
Q4 2019

Feb 14, 2020

BUY
$1.8 - $13.43 $265,244 - $1.98 Million
147,358 New
147,358 $401,000

Others Institutions Holding CYCN

# of Institutions
1
Shares Held
293K
Call Options Held
0
Put Options Held
0

About Cyclerion Therapeutics, Inc.


  • Ticker CYCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,479,800
  • Market Cap $153M
  • Description
  • Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...
More about CYCN
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.